Melasma Treatment Guidelines

Introduction to Melasma Treatment

• The American Academy of Dermatology recommends starting with triple combination cream (hydroquinone 4%, tretinoin 0.05%, and fluocinolone acetonide 0.01%) combined with strict sun protection (SPF 50+ broad-spectrum sunscreen reapplied every 2-3 hours) for the treatment of melasma 1, 2

First-Line Treatment Approach

• Apply broad-spectrum sunscreen with minimum SPF 30, preferably SPF 50+, reapplied every 2-3 hours during outdoor exposure 1, 2
• Wear wide-brimmed hats (>3-inch brim) when outdoors 1
• Seek shade during peak UV hours (10 a.m. to 4 p.m.) 1
• Use UV-protective clothing with tight weave fabrics and darker colors 1
• Avoid tanning beds and sunlamps completely 1
• Tretinoin can be used alone or combined with hydroquinone for enhanced efficacy 1
• Corticosteroids are combined with hydroquinone and tretinoin in triple formulations to reduce irritation and enhance penetration 1

Second-Line Treatment for Inadequate Response

• Administer 4 intradermal PRP treatment sessions spaced every 2-3 weeks 3, 2
• Inject intradermally at 1 cm intervals across affected areas 2
• Follow-up evaluation one month after the last treatment 3
• Maintenance treatments every 6 months as melasma is a chronic condition with high recurrence rates 1, 2
• PRP shows significantly better results than intradermal tranexamic acid injections with similar side effect profiles 3, 1, 2
• Significant improvement in melasma within 6 weeks as measured by modified Melasma Area and Severity Index (mMASI) scores 3, 1, 2

Oral Tranexamic Acid as Adjunctive Therapy

• Consider oral tranexamic acid 250 mg twice daily, particularly when combined with PRP injections 1, 2
• PRP combined with oral tranexamic acid demonstrates higher total efficacy (90.48%) compared to tranexamic acid alone (73.68%) with lower disease recurrence rates 1, 2

Treatment Algorithm

• Continue sun protection and topical therapy 2
• Add intradermal PRP injections every 2-3 weeks for 4 sessions 2
• Consider adding oral tranexamic acid 250 mg twice daily for enhanced efficacy 1, 2

Measuring Treatment Success

• Use standardized mMASI scores to objectively track improvement 1, 2
• Decreases in MASI >60-90% indicate moderate improvement 3, 1
• Decreases in MASI >90% indicate excellent response 3, 1
• Patient satisfaction assessment should complement objective measurements 3, 1

Critical Pitfalls to Avoid

• Discontinuing treatment too early—melasma is a chronic condition requiring long-term maintenance therapy 2
• Forgetting to reapply sunscreen after swimming, sweating, or after 2-3 hours of continuous exposure 1
• Failing to address hormonal influences (pregnancy, oral contraceptives, hormone replacement therapy) that may limit treatment success 1
• Counsel patients to avoid smoking, which can worsen melasma 1

Alternative Considerations

• Microneedling may be more effective than intradermal PRP injections for melasma treatment in some patients 1, 4
• Consider microneedling as alternative to PRP if PRP is unavailable or ineffective 1

Laser Therapy Risks in Darker Skin Types (Fitzpatrick IV‑VI)

Safety Considerations

Microneedling in the Management of Melasma – Evidence‑Based Recommendations

Efficacy and Safety Compared with Laser

• Microneedling carries a very low risk of post‑inflammatory hyperpigmentation in patients with Fitzpatrick skin types III–VI, markedly lower than that reported for laser therapy. 6
• The procedure results in minimal downtime (≈24–48 h), which is shorter than that required for most alternative modalities. 6
• It can be safely applied to all skin types, including thin, sensitive, and ethnic skin, without increasing adverse events. 6
• Overall safety profile is favorable: no serious adverse events have been reported in the cited studies, and the risk of hyperpigmentation or bruising is minimal when needle depth does not exceed 2.5 mm. 6
• Compared with laser, microneedling is considerably safer for darker skin types, reducing the likelihood of burns, hypo‑ or hyperpigmentation. 6

Procedural Parameters

• Needle depth should be set between 0.25 mm and 2.5 mm, selected according to the treatment area and desired tissue effect. [7][6]
• The technique induces neovascularization and neocollagenesis through controlled micro‑injury, contributing to pigment reduction and skin remodeling. [7][6]

Pre‑Procedure Preparation

• Apply a compounded topical anesthetic at least 30 minutes before microneedling to improve patient comfort. 6
• Ensure the skin is well lubricated with a topical agent or platelet‑rich plasma (PRP) to prevent a pulling sensation during needle penetration. 6

Contra‑Indications and Practical Tips

• Avoid microneedling over tattoos or permanent makeup to prevent pigment disturbance. 6

Post‑Procedure Care

• Sun avoidance for the first 24 hours after treatment is recommended to minimize inflammatory pigment changes. 6
• Refrain from using facial creams or products containing strong fragrances for 24 hours post‑procedure to reduce irritation. 6

Strength of evidence: The cited data are derived from a 2025 review in Periodontology 2000; specific grading (e.g., Level I, II) was not provided in the source.

Hormonal Management in Melasma

Use of Exogenous Hormones

• The American Academy of Dermatology indicates that women with diagnosed melasma may continue using exogenous hormones such as oral contraceptives or hormone replacement therapy when these agents are required for other medical indications, despite the potential for pigmentation worsening. 8

Microneedling for Melasma: Evidence‑Based Mechanisms and Clinical Guidance

Mechanism of Action

• Microneedling creates controlled micro‑injuries that trigger neovascularization and neocollagenesis, thereby normalizing melanocyte activity and reducing pigmentation while posing a low risk of post‑inflammatory hyperpigmentation, especially in darker skin types. 9
• Using a 12‑needle device produces mechanical trauma that activates the wound‑healing cascade, leading to rapid neocollagenesis and tissue repair through neovascularization. 9
• The microchannels formed by needles 0.5–2.0 mm deep permit deep transdermal delivery of topical agents, physically “pushing” growth factors and medications into the epidermis and dermis. 9
• Application of platelet‑rich plasma (PRP) during microneedling releases growth factors (e.g., PDGF, TGF‑β) that stimulate collagen synthesis, improve skin texture, and promote tissue repair. 9

Safety Profile

• Microneedling is associated with minimal downtime of 24–48 hours, which is shorter than most alternative melasma therapies. 9
• The procedure is safe across all Fitzpatrick skin types (III–VI), including thin, sensitive, and ethnic skin, without an increase in adverse events. 9

Treatment Protocol – PRP Timing

• Applying PRP before microneedling maximizes efficacy because the needling action drives growth factors into the skin; this pre‑application approach yields superior clinical outcomes compared with post‑procedure application. 10
• PRP should be used while in its most liquid state; platelet‑rich fibrin (PRF) begins to clot within 20–40 minutes after preparation, so timely application is essential. 10
• Applying topical agents after microneedling provides no additional benefit and is considered a critical procedural error. 10

Evidence‑Based Recommendations for Melasma Management

Comparative Efficacy of PRP

• Intradermal platelet‑rich plasma (PRP) injections achieve significantly higher clinical efficacy than tranexamic‑acid injections while maintaining a comparable safety profile, based on comparative studies reported in the 2025 guideline (Periodontology 2000)【11】.

Need for Chronic Maintenance Therapy

• Melasma must be treated as a chronic dermatologic condition; long‑term maintenance therapy and regular follow‑up visits are essential to sustain improvement and prevent relapse (Periodontology 2000 2025)【12】.

Treatment Hierarchy and Role of Laser Therapy

• The 2025 guideline (Periodontology 2000) prioritizes topical triple‑combination therapy and PRP (or microneedling with PRP) as first‑ and second‑line options, respectively; laser procedures are reserved only for refractory cases after a thorough risk‑benefit discussion and should be performed with low‑energy settings (Periodontology 2000 2025)【11】【12】.

• Second‑line therapy consists of four intradermal PRP sessions spaced 2–3 weeks apart, with optional adjunctive oral tranexamic acid 250 mg twice daily for additional benefit (Periodontology 2000 2025)【11】【12】.

Safety Considerations for First‑Line Topical Melasma Therapy

Contraindications

• Pregnancy: Tretinoin is classified as pregnancy category C; therefore all tretinoin‑containing topical products should be avoided in pregnant patients. (American Academy of Dermatology) 13, 14
• Known hypersensitivity: Patients with documented allergy to hydroquinone, tretinoin, corticosteroids, or any component of the triple‑combination formulation should not receive this therapy. (American Academy of Dermatology) 13, 14
• Nursing mothers: The extent to which hydroquinone or tretinoin is transferred into breast milk after topical application is unknown; consequently, use is not recommended during lactation. (American Academy of Dermatology) 13, 14
• Children < 10 years: Safety of topical tretinoin has not been established in children younger than ten years; the formulation should be avoided in this age group. (American Academy of Dermatology) 13, 14

Expected Adverse Effects and Management

• Local skin reactions: The most common side effects are mild erythema, peeling, dryness, burning, and irritation confined to the application site; these events are generally transient and low‑grade. (American Academy of Dermatology) 13, 14
• Interaction with irritant agents: Concomitant use of keratolytic or other photosensitizing agents should be avoided, as they can increase the likelihood and severity of irritation. (American Academy of Dermatology) 13, 14